Compass Therapeutics Inc
(CMPX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2000 | 12-1999 | 09-1999 | 06-1999 | 03-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,330 | 2,660 | 1,430 | 2,860 | 2,100 |
| Depreciation Amortization | 1,560 | 940 | 460 | 800 | 610 |
| Other Working Capital | -1,110 | -130 | 110 | -3,670 | -3,620 |
| Other Operating Activity | -1,000 | -1,000 | -1,120 | 270 | 0 |
| Operating Cash Flow | $2,780 | $2,470 | $880 | $260 | $-910 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 410 | 740 | 840 | -780 | -260 |
| Net Acquisitions | -12,590 | -12,590 | -10,740 | 0 | -3,650 |
| Other Investing Activity | 0 | 0 | 0 | -3,710 | 0 |
| Investing Cash Flow | $-12,180 | $-11,850 | $-9,900 | $-4,490 | $-3,910 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 11,310 | 10,830 | 10,700 | 3,860 | 4,210 |
| Financing Cash Flow | $11,310 | $10,830 | $10,700 | $3,860 | $4,210 |
| Exchange Rate Effect | -140 | -20 | 40 | 0 | 0 |
| Beginning Cash Position | 560 | 560 | 560 | 920 | 920 |
| End Cash Position | 2,430 | 1,980 | 2,290 | 560 | 300 |
| Net Cash Flow | $1,870 | $1,420 | $1,730 | $-350 | $-620 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,780 | 2,470 | 880 | 260 | -910 |
| Free Cash Flow | 2,780 | 2,470 | 880 | 260 | -910 |